Bristol-Myers Squibb Halts Hepatitis C Drug Research Trial After…

What looked like a promising drug to cure Hepatitis C is no longer in the pipeline. With one dead and eight hospitalized, including a woman needing a heart transplant, the future of the drug is...

(PRWeb August 28, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog